2026-04-13T14:56:41Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/224472025-12-05T16:26:34Zcom_2072_1057col_2072_478917col_2072_478921

00925njm 22002777a 4500 dc Mukhtyar, C. author Guillevin, Loïc author Cid Xutglà, M. Cinta author Dasgupta, Bhaskar author Groot, K. de author Gross, W. author Hauser, T. author Hellmich, B. author Jayne, David author Kallenberg, Cees G. M. author Merkel, Peter A. author Raspe, H. author Salvarani, Carlo author Scott, D. G. I. author Stegeman, C. author Watts, Richard A. author Westman, K. author Witter, J. author Yazici, H. author Luqmani, R. A. author 2012-03-05T12:52:09Z 2012-03-05T12:52:09Z 2008 Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice. Vasculitis Vasos sanguinis Protocols clínics Vasculitis Blood-vessels Medical protocols EULAR recommendations for the management of primary small and medium vessel vasculitis.